1 By jay In Press ReleasesPosted January 6, 2021Axial Therapeutics to Present at the Inaugural Virtual H.C. Wainwright BioConnect ConferenceJanuary 6, 2021 READ MORE
0 By jay In Press ReleasesPosted January 4, 2021Axial Therapeutics to Present at the ACCESS CHINA Forum @JPM WEEK 2021December 30, 2020 READ MORE
0 By jay In Press ReleasesPosted December 8, 2020Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company ConferenceDec. 8, 2020 READ MORE
6 By jay In Press ReleasesPosted December 3, 2020Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other SymptomsDec. 3, 2020 READ MORE
0 By jay In Press ReleasesPosted November 25, 2020Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNovember 25, 2020 READ MORE
0 By jay In Press ReleasesPosted November 16, 2020Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci CapitalNovember 16, 2020 READ MORE
0 By jay In Press ReleasesPosted September 22, 2020Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical ScienceSeptember 22, 2020 READ MORE
0 By jay In Press ReleasesPosted September 15, 2020Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember, 15, 2020 READ MORE
0 By jay In Press ReleasesPosted August 17, 2020Axial Biotherapeutics to Present at The JMP Securities CNS ForumAugust 12, 2020 READ MORE
1 By jay In Press ReleasesPosted July 28, 2020Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease TherapeuticsJuly 28, 2020 READ MORE
